Jaime Bartushak - 07 Nov 2024 Form 4 Insider Report for Citius Pharmaceuticals, Inc. (CTXR)

Role
Chief Financial Officer
Signature
/s/ Alexander M. Donaldson, by power of attorney
Issuer symbol
CTXR
Transactions as of
07 Nov 2024
Net transactions value
$0
Form type
4
Filing time
12 Nov 2024, 17:00:27 UTC
Previous filing
14 Aug 2024
Next filing
16 Dec 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CTXR Common Stock 60,353 07 Nov 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CTXR Stock Option (Right to Purchase Common Stock) Award $0 +350,000 $0.000000 350,000 07 Nov 2024 Common Stock 350,000 $0.3800 Direct F1
holding CTXR Stock Option (Right to Purchase Common Stock) 300,000 07 Nov 2024 Common Stock 300,000 $0.7000 Direct F2
holding CTXR Stock Option (Right to Purchase Common Stock) 300,000 07 Nov 2024 Common Stock 300,000 $1.25 Direct F3
holding CTXR Stock Option (Right to Purchase Common Stock) 300,000 07 Nov 2024 Common Stock 300,000 $2.04 Direct F4
holding CTXR Stock Option (Right to Purchase Common Stock) 100,000 07 Nov 2024 Common Stock 100,000 $2.00 Direct F4
holding CTXR Stock Option (Right to Purchase Common Stock) 125,000 07 Nov 2024 Common Stock 125,000 $1.01 Direct F4
holding CTXR Stock Option (Right to Purchase Common Stock) 100,000 07 Nov 2024 Common Stock 100,000 $0.6700 Direct F4
holding CTXR Stock Option (Right to Purchase Common Stock) 70,000 07 Nov 2024 Common Stock 70,000 $1.62 Direct F4
holding CTXR Stock Option (Right to Purchase Common Stock) 25,000 07 Nov 2024 Common Stock 25,000 $3.45 Direct F4
holding CTXR Stock Option (Right to Purchase Common Stock) 48,267 07 Nov 2024 Common Stock 48,267 $10.50 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options were granted on November 7, 2024. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company on each such vesting date
F2 The options were granted on October 10, 2023. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company on each such vesting date.
F3 The options were granted on October 4, 2022. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company on each such vesting date.
F4 The options are vested in full and exercisable immediately.